RAXAR Drug Patent Profile
✉ Email this page to a colleague
When do Raxar patents expire, and when can generic versions of Raxar launch?
Raxar is a drug marketed by Otsuka and is included in one NDA.
The generic ingredient in RAXAR is grepafloxacin hydrochloride. Additional details are available on the grepafloxacin hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for RAXAR?
- What are the global sales for RAXAR?
- What is Average Wholesale Price for RAXAR?
Summary for RAXAR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 51 |
Patent Applications: | 4,824 |
Formulation / Manufacturing: | see details |
DailyMed Link: | RAXAR at DailyMed |
![RAXAR drug patent expirations Drug patent expirations by year for RAXAR](/p/graph/s/t/RAXAR-patent-expirations.png)
US Patents and Regulatory Information for RAXAR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Otsuka | RAXAR | grepafloxacin hydrochloride | TABLET;ORAL | 020695-001 | Nov 6, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Otsuka | RAXAR | grepafloxacin hydrochloride | TABLET;ORAL | 020695-002 | May 14, 1998 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Otsuka | RAXAR | grepafloxacin hydrochloride | TABLET;ORAL | 020695-003 | May 14, 1998 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for RAXAR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Otsuka | RAXAR | grepafloxacin hydrochloride | TABLET;ORAL | 020695-001 | Nov 6, 1997 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for RAXAR
See the table below for patents covering RAXAR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
China | 1053666 | ⤷ Sign Up | |
Japan | H0696557 | ⤷ Sign Up | |
Japan | H03135930 | BENZENE DERIVATIVE | ⤷ Sign Up |
Denmark | 101492 | ⤷ Sign Up | |
Germany | 3856434 | ⤷ Sign Up | |
Singapore | 49836 | Benzoheterocyclic compounds | ⤷ Sign Up |
Germany | 3855388 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for RAXAR
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0287951 | SPC/GB98/016 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: GREPAFLOXACIN, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT INCLUDING GREPAFLOXACIN HYDROCHLORIDE SESQUIHYDRATE; REGISTERED: DE 40682.00.00 19970731; DE 40682.01.00 19970731; DE 40682.02.00 19970731; UK 10949/0299 19971209; UK 10949/0300 19971209 |
0451216 | 99C0028 | Belgium | ⤷ Sign Up | PRODUCT NAME: GREPAFLOXACINE; CHLORHYDRATE SESQUIHYDRATE; NAT. REGISTRATION NO/DATE: NL 23 373 19990525; FIRST REGISTRATION: DE - 4062.00.00 19970731 |
0287951 | C980011 | Netherlands | ⤷ Sign Up | PRODUCT NAME: GREPAFLOXACINUM, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AA NVAARDBAAR ZOUT OF IN DE VORM VAN EEN ESTER MET EEN ALKANOL MET 1-6 KOOLSTOFATOMEN, IN HET BIJZONDER GREPAFLOXACINI HYDROCHLOR IDUM SESQUIHYDRATUM; NAT. REGISTRATION NO/DATE: RVG 21894, RVG 21895 19971113; FIRST REGISTRATION: DE 40682.00.00, 40682.01.00, 40682.02.00 19970731 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |